Literature DB >> 19962291

Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial.

Simone Krebs1, Talib N Omer, Bilal Omer.   

Abstract

Suppression of tumour necrosis factor alpha (TNF-alpha) and other interleukins by wormwood (Artemisia absinthium) extracts were reported recently in in vitro studies. The aim of the present study was to find out if this effect can be also be observed in Crohn's Disease (CD) patients where TNF-alpha appears to play an important role. In a controlled trial, 10 randomly selected patients suffering from CD were given in addition to their basic CD therapy 3x750mg dried powdered wormwood for 6 weeks. Ten patients, also randomly selected who met the inclusion criteria served as control group. Minimum score of 200 on Crohn's Disease Activity Index (CDAI) was required at baseline for inclusion in each group. Patients who received infliximab or similar were excluded from the trial. TNF-alpha level in serum were measured at baseline, and after three and six weeks. During this period all concomitant CD medications was maintained at the baseline dose levels. Average serum TNF-alpha level fell from 24.5+/-3.5pg/ml at baseline to 8.0+/-2.5pg/ml after six weeks. The corresponding levels in the control group were 25.7+/-4.6 (week 0), and 21.1+/-3.2 (week 6). On the clinical side, CDAI scores fell from 275+/-15 to below 175+/-12 in wormwood group with remission of symptoms in eight patients (CDAI score below 170 or reduction by 70 points), compared to only two in the placebo group (CDAI of placebo group 282+/-11 at baseline and 230+/-14 on week 6). IBDQ also reflected accelerated clinical response with wormwood. Of clinical significance were the findings that wormwood also improved mood of the CD patients, as reflected in Hamilton's Depression Scale. These findings provide a base to test wormwood in clinical conditions thought to be mediated by increased production of pro-inflammatory cytokines such as TNF-alpha. Copyright 2009. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962291     DOI: 10.1016/j.phymed.2009.10.013

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  22 in total

1.  Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

Review 2.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Authors:  Stefanie Joos
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

Review 3.  Natural Treatments for Fissure in Ano Used by Traditional Persian Scholars, Razi (Rhazes) and Ibn Sina (Avicenna).

Authors:  Ali Reza Derakhshan
Journal:  J Evid Based Complementary Altern Med       Date:  2016-06-23

4.  Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.

Authors:  Islam Khan; Sue E Samson; Ashok Kumar Grover
Journal:  Med Princ Pract       Date:  2017-03-08       Impact factor: 1.927

Review 5.  Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.

Authors:  K Simon Yeung; Marisol Hernandez; Jun J Mao; Ingrid Haviland; Jyothirmai Gubili
Journal:  Phytother Res       Date:  2018-02-21       Impact factor: 5.878

6.  The effect of menthol supplement diet on colitis-induced colon tumorigenesis and intestinal microbiota.

Authors:  Lei Luo; Jing Yan; Bingyu Chen; Yi Luo; Lina Liu; Zhiguang Sun; Yin Lu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

7.  Allium cepa L. and Quercetin Inhibit RANKL/Porphyromonas gingivalis LPS-Induced Osteoclastogenesis by Downregulating NF-κB Signaling Pathway.

Authors:  Tatiane Oliveira; Camila A Figueiredo; Carlos Brito; Alexander Stavroullakis; Ana Carolina Ferreira; Getulio Nogueira-Filho; Anuradha Prakki
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-26       Impact factor: 2.629

Review 8.  Herbal and plant therapy in patients with inflammatory bowel disease.

Authors:  Aikaterini Triantafyllidi; Theodoros Xanthos; Apostolos Papalois; John K Triantafillidis
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

9.  Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.

Authors:  P Skopiński; B J Bałan; J Kocik; R Zdanowski; S Lewicki; M Niemcewicz; K Gawrychowski; E Skopińska-Różewska; W Stankiewicz
Journal:  Mediators Inflamm       Date:  2013-06-27       Impact factor: 4.711

Review 10.  Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review.

Authors:  Francesca Algieri; Alba Rodriguez-Nogales; M Elena Rodriguez-Cabezas; Severiano Risco; M Angeles Ocete; Julio Galvez
Journal:  Mediators Inflamm       Date:  2015-10-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.